FDA Orange Book
Is there a generic for Natroba?
Natroba contains spinosad. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Natroba (spinosad). The Orange Book shows its last listed patent expires November 25, 2033.
Run it in Rivvi
Map Natroba and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Natroba products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| suspension, topical | 0.9% | Marketed (Rx) | None | 0 | None |
NDA 022408, held by CIPHER PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Natroba patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9895388 | November 25, 2033 | Method of use | U-3365 | 022408 |
Natroba NDC codes
Questions
Is there a generic for Natroba?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Natroba (spinosad). The Orange Book shows its last listed patent expires November 25, 2033.
What is the generic name for Natroba?
The active ingredient in Natroba is spinosad, per the FDA Orange Book.
When does the Natroba patent expire?
The last patent listed for Natroba in the Orange Book expires November 25, 2033. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.